.jpg?width=690&height=468&name=AI-ML-in-life-sciences%20(1).jpg)
FEATURED CONTENT
The Evolution and Future of Integrated Evidence Planning
Our latest white paper, authored by RWE experts from GSK, Novo Nordisk and Axtria, explores the most recent innovations in Integrated Evidence Planning (IEP). As treatments evolve, IEP brings a fundamental shift for biopharma companies in their pursuit of improving patient outcomes. Learn how industry pioneers are using IEP along with real-world data and AI across a variety of use cases.
SPECIAL REPORT
Gartner® Hype Cycle™ for Life Science Commercial Operations, 2024
We’re proud to be recognized for six technologies in the Gartner® Hype Cycle™ for Life Science Commercial Operations, 2024. This report tracks key technology trends, maturity levels, and adoption rates, enabling life sciences organizations to evaluate and prioritize technologies that align with their vision and enterprise goals. Get complimentary access to the full report here!
IGNITE WEBINAR
Going Beyond Pilots: Implementing GenAI for True Value Generation
While many life sciences organizations are experimenting with GenAI, scaling and deploying these solutions remains challenging for most of them. In this on-demand webinar, Axtria leaders discuss the future of GenAI-based value creation, the seven pillars of GenAI success, and a framework for driving enterprise-level value.
INDUSTRY PRIMER
Power of Customer Centricity
Customer centricity is a key strategy for long-term business success. This article explains why businesses should place customers at the center of all business decisions, how to create a customer-centric strategy, and how this approach can be applied for life sciences companies.
ESG REPORT 2024
Progress through Partnerships
Axtria's 2024 ESG report highlights our commitment to sustainable growth. The report details initiatives that reduce environmental impact, foster a supportive workplace culture, and ensure ethical business practices. Download the report to learn how Axtria is making a difference globally.
LEADERS' PERSPECTIVES
Seven Pillars of GenAI for Enterprise-Level Value Generation
Authored by Axtria thought leaders and featured in Pharmaphorum, this article introduces the "Seven Pillars" framework for maximizing Generative AI’s enterprise-level impact in life sciences. Discover how each pillar - from data strategy to responsible AI - fuels growth and innovation.
TIMELESS INSIGHTS
Shaping the Future of Pharma Innovation With GenAI
From accelerating drug discovery to optimizing clinical trials, the potential for GenAI to reshape pharmaceutical operations is vast. Learn how GenAI is transforming the life sciences industry by driving technical innovation and business growth, instilling a sense of optimism about the future.
NEWS CAPSULE
Axtria Showcases AI-Powered Innovations at PMSA 2024 Fall Symposium
The PMSA 2024 Fall Symposium, held in Chicago on October 3-4, 2024, brought together industry leaders, researchers, and academics to explore the transformative impact of AI in healthcare. Axtria’s experts, alongside client partners, led insightful presentations and discussions, showcasing advanced AI-driven solutions and strategies tailored for the pharmaceutical industry.
Interactive Panel Sessions at NEXT Pharma CX & AI Summit
On October 22-23, 2024, in Vienna, Austria, NEXT Pharma CX & AI Summit featured two interactive panels hosted by Axtria experts with global pharmaceutical leaders. The sessions featured insights on enhancing commercial excellence and optimizing customer journeys with AI and data-driven insights.
Reuters Pharma Customer Engagement USA Summit
We had an incredible time at the Reuters Events Pharma Customer Engagement USA 2024 Conference in Philadelphia! The event brought together over 350 pharma leaders from the commercial, marketing, medical affairs, and data sectors to discuss and innovate on customer engagement strategies. We also hosted a well-attended workshop, "Reimagining the Customer Engagement Model in a Transformed and Integrated Health System Environment."
